Amerisafe (AMSF) reported $75.75 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 0.3%. EPS of $0.60 for the same period compares to $0.69 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $76.83 million, representing a surprise of -1.41%. The company delivered an EPS surprise of +1.69%, with the consensus EPS estimate being $0.59.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Amerisafe performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Net investment income: $6.65 million versus the two-analyst average estimate of $6.85 million. The reported number represents a year-over-year change of -9.7%.
- Revenues- Fee and other income: $0.21 million versus $0.18 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +70.7% change.
- Revenues- Net premiums earned: $68.89 million versus the two-analyst average estimate of $69.81 million. The reported number represents a year-over-year change of +0.6%.
View all Key Company Metrics for Amerisafe here>>>
Shares of Amerisafe have returned -6.7% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AMERISAFE, Inc. (AMSF): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
